Abiopharma

New Form 4/A - Celularity Inc Filed: 2026-01-15 AccNo: 0001493152-26-002424 Size: 5 KB

New Form 4/A - Celularity Inc Filed: 2026-01-15 AccNo: 0001493152-26-002427 Size: 5 KB

New Form 4/A - Celularity Inc Filed: 2026-01-15 AccNo: 0001493152-26-002425 Size: 5 KB

UTHR: Notification

New Form SCHEDULE 13G - Century Therapeutics, Inc. Filed: 2026-01-15 AccNo: 0001172661-26-000198 Size: 14 KB

Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026

A New Press Release from Oncolytics Biotech, Inc

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

New Form 3 - KORU Medical Systems, Inc. Filed: 2026-01-15 AccNo: 0001161697-26-000029 Size: 10 KB

New Form SCHEDULE 13G/A - Sharps Technology Inc. Filed: 2026-01-15 AccNo: 0001062993-26-000282 Size: 11 KB

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

New Form SCHEDULE 13G/A - Sharps Technology Inc. Filed: 2026-01-15 AccNo: 0001062993-26-000280 Size: 11 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

New Form SCHEDULE 13G - Sharps Technology Inc. Filed: 2026-01-15 AccNo: 0001062993-26-000278 Size: 15 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.